ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,317,000 | -24.3% | 10,220 | 0.0% | 0.01% | -22.2% |
Q4 2020 | $1,739,000 | +11.8% | 10,220 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $1,556,000 | +1.0% | 10,220 | -3.7% | 0.01% | -10.0% |
Q2 2020 | $1,541,000 | +25.2% | 10,610 | 0.0% | 0.01% | +11.1% |
Q1 2020 | $1,231,000 | – | 10,610 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |